{"transactions":[{"id":1674550,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":95028,"kind":"person","name":"Morberg John D","position":1,"cik":"0001345964","reported_name":"Morberg John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-01-22T19:26:42.000Z","date":"2024-01-18","kind":"exercise","planned":false,"acquired":false,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vested on January 18, 2024."}],"balance_after":0,"derivative":{"exercise_date":"2024-01-18","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001628280-24-001842","document":"wk-form4_1705951591.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000162828024001842/wk-form4_1705951591.xml","form_type":"4"}},{"id":1674549,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":95028,"kind":"person","name":"Morberg John D","position":1,"cik":"0001345964","reported_name":"Morberg John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-01-22T19:26:42.000Z","date":"2024-01-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":6283,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis."}],"balance_after":125617,"source":{"system":"sec-edgar","filing":"0001628280-24-001842","document":"wk-form4_1705951591.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000162828024001842/wk-form4_1705951591.xml","form_type":"4"}},{"id":1674548,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":95028,"kind":"person","name":"Morberg John D","position":1,"cik":"0001345964","reported_name":"Morberg John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-01-22T19:26:42.000Z","date":"2024-01-18","kind":"exercise","planned":false,"acquired":true,"shares":17500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis."}],"balance_after":131900,"source":{"system":"sec-edgar","filing":"0001628280-24-001842","document":"wk-form4_1705951591.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000162828024001842/wk-form4_1705951591.xml","form_type":"4"}},{"id":1868041,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":95028,"kind":"person","name":"Morberg John D","position":1,"cik":"0001345964","reported_name":"Morberg John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-06-05T19:24:12.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Restricted Stock Units will vest on the 3rd anniversary of the grant date or if earlier, upon a Change in Control."}],"balance_after":114400,"source":{"system":"sec-edgar","filing":"0001628280-23-020839","document":"wk-form4_1685993042.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000162828023020839/wk-form4_1685993042.xml","form_type":"4"}},{"id":1868040,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":95028,"kind":"person","name":"Morberg John D","position":1,"cik":"0001345964","reported_name":"Morberg John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-06-05T19:24:12.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":45000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted Stock Units will vest on the 3rd anniversary of the grant date."}],"balance_after":64400,"source":{"system":"sec-edgar","filing":"0001628280-23-020839","document":"wk-form4_1685993042.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000162828023020839/wk-form4_1685993042.xml","form_type":"4"}},{"id":2185974,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":95028,"kind":"person","name":"Morberg John D","position":1,"cik":"0001345964","reported_name":"Morberg John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-08-15T22:39:46.000Z","date":"2022-08-11","kind":"grant","acquired":true,"shares":13500,"price":11.31,"value":152685.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted Stock Units will vest on the 3rd anniversary of the grant date and will be automatically settled in shares of common stock."}],"balance_after":13500,"derivative":{"exercise_date":"2025-08-11","underlying":"Common Stock","underlying_shares":13500},"source":{"system":"sec-edgar","filing":"0001628280-22-022940","document":"wf-form4_166060256850518.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000162828022022940/wf-form4_166060256850518.xml","form_type":"4"}},{"id":2185973,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":95028,"kind":"person","name":"Morberg John D","position":1,"cik":"0001345964","reported_name":"Morberg John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2022-08-15T22:39:46.000Z","date":"2022-08-11","kind":"grant","acquired":true,"shares":12591,"price":11.31,"value":142404.21,"ownership":{"direct":true},"balance_after":13000,"derivative":{"exercise_price":11.31,"exercise_date":"2023-08-11","expiration_date":"2029-08-11","underlying":"Common Stock","underlying_shares":12591},"source":{"system":"sec-edgar","filing":"0001628280-22-022940","document":"wf-form4_166060256850518.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000162828022022940/wf-form4_166060256850518.xml","form_type":"4"}},{"id":2185972,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":95028,"kind":"person","name":"Morberg John D","position":1,"cik":"0001345964","reported_name":"Morberg John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Incentive Stock Option (Right to Buy)","published_at":"2022-08-15T22:39:46.000Z","date":"2022-08-11","kind":"grant","acquired":true,"shares":409,"price":11.31,"value":4625.79,"ownership":{"direct":true},"balance_after":409,"derivative":{"exercise_price":11.31,"exercise_date":"2023-08-11","expiration_date":"2029-08-11","underlying":"Common Stock","underlying_shares":409},"source":{"system":"sec-edgar","filing":"0001628280-22-022940","document":"wf-form4_166060256850518.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000162828022022940/wf-form4_166060256850518.xml","form_type":"4"}},{"id":2206467,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":95028,"kind":"person","name":"Morberg John D","position":1,"cik":"0001345964","reported_name":"Morberg John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Incentive Stock Option (Right to Buy)","published_at":"2022-07-18T21:02:38.000Z","date":"2022-07-14","kind":"grant","acquired":true,"shares":9771,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9771,"derivative":{"exercise_price":9.76,"exercise_date":"2023-07-14","expiration_date":"2029-07-14","underlying":"Common Stock","underlying_shares":9771},"source":{"system":"sec-edgar","filing":"0001628280-22-019063","document":"wf-form4_165817814166337.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000162828022019063/wf-form4_165817814166337.xml","form_type":"4"}},{"id":2206466,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":95028,"kind":"person","name":"Morberg John D","position":1,"cik":"0001345964","reported_name":"Morberg John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2022-07-18T21:02:38.000Z","date":"2022-07-14","kind":"grant","acquired":true,"shares":40229,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":40229,"derivative":{"exercise_price":9.76,"exercise_date":"2023-07-14","expiration_date":"2029-07-14","underlying":"Common Stock","underlying_shares":40229},"source":{"system":"sec-edgar","filing":"0001628280-22-019063","document":"wf-form4_165817814166337.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000162828022019063/wf-form4_165817814166337.xml","form_type":"4"}},{"id":2206465,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":95028,"kind":"person","name":"Morberg John D","position":1,"cik":"0001345964","reported_name":"Morberg John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-07-18T21:02:38.000Z","date":"2022-07-14","kind":"grant","acquired":true,"shares":5123,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted Stock Units will vest on the 3rd anniversary of the grant date and will be automatically settled in shares of common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted Stock Units will vest on the 3rd anniversary of the grant date and will be automatically settled in shares of common stock."}],"balance_after":5123,"derivative":{"exercise_date":"2025-07-14","underlying":"Common Stock","underlying_shares":5123},"source":{"system":"sec-edgar","filing":"0001628280-22-019063","document":"wf-form4_165817814166337.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000162828022019063/wf-form4_165817814166337.xml","form_type":"4"}},{"id":2623334,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":95028,"kind":"person","name":"Morberg John D","position":1,"cik":"0001345964","reported_name":"Morberg John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2021-07-28T22:13:42.000Z","date":"2021-07-27","kind":"grant","acquired":true,"shares":5746,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5746,"derivative":{"exercise_price":12.14,"exercise_date":"2022-07-27","expiration_date":"2028-07-27","underlying":"Common Stock","underlying_shares":5746},"source":{"system":"sec-edgar","filing":"0001593968-21-001898","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000159396821001898/primary_01.xml","form_type":"4"}},{"id":2623333,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":95028,"kind":"person","name":"Morberg John D","position":1,"cik":"0001345964","reported_name":"Morberg John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Non-Qualified StockOption (right to buy)","published_at":"2021-07-28T22:13:42.000Z","date":"2021-07-27","kind":"grant","acquired":true,"shares":59254,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":59254,"derivative":{"exercise_price":12.14,"exercise_date":"2022-07-27","expiration_date":"2028-07-27","underlying":"Common Stock","underlying_shares":59254},"source":{"system":"sec-edgar","filing":"0001593968-21-001898","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000159396821001898/primary_01.xml","form_type":"4"}},{"id":2744331,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":95028,"kind":"person","name":"Morberg John D","position":1,"cik":"0001345964","reported_name":"Morberg John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-04-20T22:23:13.000Z","date":"2021-04-19","kind":"purchase","acquired":true,"shares":2000,"price":11.05,"value":22100.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $10.95 to $11.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":19400,"source":{"system":"sec-edgar","filing":"0001593968-21-001133","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000159396821001133/primary_01.xml","form_type":"4"}},{"id":2745921,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":95028,"kind":"person","name":"Morberg John D","position":1,"cik":"0001345964","reported_name":"Morberg John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-04-19T23:18:31.000Z","date":"2021-04-16","kind":"purchase","acquired":true,"shares":2000,"price":11.08,"value":22160.0,"ownership":{"direct":true},"balance_after":17400,"source":{"system":"sec-edgar","filing":"0001593968-21-001124","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000159396821001124/primary_01.xml","form_type":"4"}},{"id":2747651,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":95028,"kind":"person","name":"Morberg John D","position":1,"cik":"0001345964","reported_name":"Morberg John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-04-16T18:30:13.000Z","date":"2021-04-15","kind":"purchase","acquired":true,"shares":2000,"price":10.98,"value":21960.0,"ownership":{"direct":true},"balance_after":15400,"source":{"system":"sec-edgar","filing":"0001593968-21-001120","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000159396821001120/primary_01.xml","form_type":"4"}},{"id":2748893,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":95028,"kind":"person","name":"Morberg John D","position":1,"cik":"0001345964","reported_name":"Morberg John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-04-15T16:43:00.000Z","date":"2021-04-14","kind":"purchase","acquired":true,"shares":2000,"price":10.64,"value":21280.0,"ownership":{"direct":true},"balance_after":13400,"source":{"system":"sec-edgar","filing":"0001593968-21-001116","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000159396821001116/primary_01.xml","form_type":"4"}},{"id":2750815,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":95028,"kind":"person","name":"Morberg John D","position":1,"cik":"0001345964","reported_name":"Morberg John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-04-13T23:33:29.000Z","date":"2021-04-13","kind":"purchase","acquired":true,"shares":2000,"price":10.18,"value":20360.0,"ownership":{"direct":true},"balance_after":11400,"source":{"system":"sec-edgar","filing":"0001593968-21-001110","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000159396821001110/primary_01.xml","form_type":"4"}},{"id":2864384,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":95028,"kind":"person","name":"Morberg John D","position":1,"cik":"0001345964","reported_name":"Morberg John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-02-12T18:19:24.000Z","date":"2021-02-11","kind":"purchase","acquired":true,"shares":1400,"price":11.88,"value":16632.0,"ownership":{"direct":true},"balance_after":9400,"source":{"system":"sec-edgar","filing":"0001593968-21-000434","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000159396821000434/primary_01.xml","form_type":"4"}},{"id":2867364,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":95028,"kind":"person","name":"Morberg John D","position":1,"cik":"0001345964","reported_name":"Morberg John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-02-11T17:52:46.000Z","date":"2021-02-10","kind":"purchase","acquired":true,"shares":2000,"price":11.64,"value":23280.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $11.62 to $11.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":8000,"source":{"system":"sec-edgar","filing":"0001593968-21-000404","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000159396821000404/primary_01.xml","form_type":"4"}},{"id":2870006,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":95028,"kind":"person","name":"Morberg John D","position":1,"cik":"0001345964","reported_name":"Morberg John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-02-10T17:47:43.000Z","date":"2021-02-09","kind":"purchase","acquired":true,"shares":2000,"price":12.06,"value":24120.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $12.04 to $12.08, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001593968-21-000398","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000159396821000398/primary_01.xml","form_type":"4"}},{"id":2872819,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":95028,"kind":"person","name":"Morberg John D","position":1,"cik":"0001345964","reported_name":"Morberg John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-02-09T17:57:15.000Z","date":"2021-02-08","kind":"purchase","acquired":true,"shares":2000,"price":10.97,"value":21940.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $10.97 to $11.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001593968-21-000380","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000159396821000380/primary_01.xml","form_type":"4"}},{"id":2875185,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":95028,"kind":"person","name":"Morberg John D","position":1,"cik":"0001345964","reported_name":"Morberg John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-02-08T22:51:01.000Z","date":"2021-02-05","kind":"purchase","acquired":true,"shares":2000,"price":10.87,"value":21740.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $10.86 to $10.88, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001593968-21-000375","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000159396821000375/primary_01.xml","form_type":"4"}},{"id":2901103,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":95028,"kind":"person","name":"Morberg John D","position":1,"cik":"0001345964","reported_name":"Morberg John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2021-01-21T22:21:50.000Z","date":"2021-01-18","kind":"grant","acquired":true,"shares":78742,"price":10.83,"value":852775.86,"ownership":{"direct":true},"balance_after":78742,"derivative":{"exercise_price":10.83,"exercise_date":"2022-01-18","expiration_date":"2028-01-18","underlying":"Common Stock","underlying_shares":78742},"source":{"system":"sec-edgar","filing":"0001593968-21-000156","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000159396821000156/primary_01.xml","form_type":"4"}},{"id":2901102,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":95028,"kind":"person","name":"Morberg John D","position":1,"cik":"0001345964","reported_name":"Morberg John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Incentive Stock Option (Right to Buy)","published_at":"2021-01-21T22:21:50.000Z","date":"2021-01-18","kind":"grant","acquired":true,"shares":21258,"price":10.83,"value":230224.14,"ownership":{"direct":true},"balance_after":21258,"derivative":{"exercise_price":10.83,"exercise_date":"2022-01-18","expiration_date":"2028-01-18","underlying":"Common Stock","underlying_shares":21258},"source":{"system":"sec-edgar","filing":"0001593968-21-000156","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000159396821000156/primary_01.xml","form_type":"4"}},{"id":2901101,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":95028,"kind":"person","name":"Morberg John D","position":1,"cik":"0001345964","reported_name":"Morberg John D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2021-01-21T22:21:50.000Z","date":"2021-01-18","kind":"grant","acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"No exercisable date for this type of award"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted Stock Units will vest on the 3rd anniversary of the grant date and will be automatically settled in shares of common stock."}],"balance_after":17500,"derivative":{"underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001593968-21-000156","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000159396821000156/primary_01.xml","form_type":"4"}}]}